Each year millions of Americans travel to developing countries for vacation, business, study, or missionary and service activities. One of the major goals of emporiatrics is to prevent illness during these trips. However, there is very little prospective information on the health of Americans during their travel, and almost none following travel. [1] [2] [3] [4] While several studies have examined diarrhea in small numbers of travelers to single destinations, 5-8 and the incidence of malaria in returned travelers, [9] [10] [11] there is no study of a large number of Americans who differ widely in age and travel destination. Knowledge of the broad range of travel associated illness such as diarrhea, respiratory illness, skin disorders, and accidents, would enable health care providers to more effectively counsel travelers in preventive measures, and hopefully lead to improved health. This study reports on the adverse health events occurring in a large cohort of Americans during and after their travel to developing countries.
pliance with antimalarial medications. If a traveler had seen a physician upon return and there was a question about diagnosis or therapy, with the patient's consent, the physician was contacted. The study was approved by the medical school's Institutional Review Board.
Prior to travel each person was given extensive counseling and written material on the prevention of malaria and traveler's diarrhea. They were given prescriptions for prophylactic antimalarials, and instructed on self-treatment of diarrhea with hydration, antimotility agents and antibiotics. They were also immunized against vaccine-preventable illness and provided with preventive advice.
Information was entered into a data base program (File Maker, Claris Corporation, Santa Clora, CA) and analyzed. Data is presented as the mean Ϯ standard deviation. Comparison between groups were evaluated with a Student's two-tailed t-test for independent means. For analysis of factors influencing the chance of becoming ill, logistic regression models were developed. Analysis of these was carried out using the SAS data analysis package. 12 
Results

Patient Demographics
For a 2-year period, June 1989, through May 1991, 869 patients were enrolled. Follow-up was obtained on 822 (95%); 38 never traveled, leaving 784 persons who were studied. The patient and travel demographics are described in Table 1 . There was a wide age range with nearly 5% of persons age 12 years and younger, and 14% age 65 and older. Over 80% of travel was for a month or less, with a median duration of 19 days (mean 24 Ϯ 16 days). Most persons were traveling for vacation. The number visiting each region of the world is detailed in Table 2 . Although 123 countries were visited, travel to 15 countries (Kenya, India, Nepal, Thailand, Tanzania, Brazil, Ghana, Ecuador, Egypt, Guatemala, Hong Kong, Singapore, Peru, Indonesia, and South Africa) accounted for 58% of all travel. An average of 1.9 countries was visited per traveler.
Illness During Travel
An illness was reported by 64% (501) of travelers (Table 3) ; there were 795 adverse health events reported in these patients (1.6 Ϯ 0.8 events per traveler). Fiftyfour percent of travelers had returned the questionnaire postcard, and those who did not return the card or required telephone follow-up because they reported an illness, were contacted 18.0 Ϯ 15.8 days after return.
Ill travelers were younger (43.1 Ϯ 17.8 vs. 46.0 Ϯ 17.0 years, p = .023), more often female (68.0% vs. 58.7%, p = .008), and had a longer duration of travel (26.0 Ϯ 16.7 vs. 19.1 Ϯ 11.8 days, p < .001) than travelers who were not ill. Table 4 lists the incidence of illness by risk category as single variables.
Five risk factors for illness-duration of travel, age, destination (defined as region of the world), gender, and previous medical condition-were further analyzed in a logistic regression model. In this model, becoming ill was compared for persons who traveled to a destination (either alone or as part of a multidestination journey), versus those who did not travel to that destination. Duration of travel was the strongest influence on developing illness. Each day of travel added a 3.1 to 3.7% increase in incidence of illness, depending upon destination. This translated into 80% of persons who traveled for >30 days duration becoming ill, compared with 60% who traveled ≤ 30 days (see Table 4 , p < .001). When age as a continuous variable was analyzed in this model, it did not correlate with illness. Male gender was significantly protective; depending upon destination, males had a 29 to 32% reduced chance of illness (p < .025). Traveling with a previous medical condition was a neutral factor. *123 countries were visited within these regions. † The total percent exceeds 100% since some travelers visited multiple regions. Figure 1 displays the odds ratio (from the logistic regression model) for illness by region visited. Travel to the Indian subcontinent more than doubled the risk of becoming ill (79.3% of travelers became ill, p < .001). On the other hand, travel to Central and East Africa (57.1% ill, p < .05) or Southern Africa (44.1% ill, p < .001) decreased the risk by 32% and 63% respectively.
The most common illness was diarrhea, reported in 358 persons (46% of all travelers and 72% of those who reported illness). Of these, 270 travelers met a strict definition for traveler's diarrhea 6, 13 (defined in Table 3 ), and 88 had mild diarrhea termed loose motions. 6, 13 Diarrhea began a median of 7 days (mean 9.8 Ϯ 8.5 days) after arrival and lasted 3.7 Ϯ 5.6 days. Eighty percent of those with diarrhea chose to treat themselves with medication (Hill DR, data not presented), and 6% sought medical care.
Upper respiratory tract symptoms were the next most common health problem, and occurred in 204 (26%) travelers. Symptoms of cough, runny nose, or sore throat lasted 11 Ϯ 9 days. Most travelers (84%) took some form of treatment. Of these, 76% used over-the-counter symptomatic measures, and 20% used antibiotics; 8% received medical care. Five persons (3%) used steroids or asthma medications for exacerbations of underlying asthma.
Skin disorders were reported by 63 (8%) travelers. Fourteen problems were caused by stinging or biting insects, 10 by heat or sun exposure, 7 by dermatophytes, and 7 by contact allergens. Five episodes were localized infections or cellulitis, 4 miscellaneous, and 16 were from unknown causes.
Acute mountain sickness was experienced by 45 (6%) travelers. For those who reported the altitude (73%), all episodes occurred above 10,000 feet. The most common symptoms were headache (58%), shortness of breath (31%), fatigue (27%), nausea (20%), and dizziness (20%). Treatment options exercised were rest (22%), acetazolamide (18%), descent (16%), oxygen (7%), and symptomatic measures such as the use of over-the-counter analgesics (11%); 31% had no specific therapy. Forty episodes of motion sickness were experienced by 37 (5%) persons. There were 17 episodes of car or train sickness, 13 of sea sickness, and 10 of air sickness. Antihistamine based products were used by 59% of those who took a medication.
Thirty-five persons (4%) sustained accidents or injuries. Eleven sustained lacerations, abrasions or burns, 10 had minor trauma usually secondary to falls, 4 were involved in vehicular accidents, 4 experienced robbery or assault, 2 had near drowning, 2 sustained trauma requiring surgery, and 2 had miscellaneous injuries. Four of the 35 patients required medical care for their injuries, and 84% of the injuries occurred in rural settings.
Febrile episodes occurred in 100 (13%) travelers, however, in 79% of cases, fever occurred in association with a defined illness, usually diarrhea or upper respiratory infections. There were 21 individuals with fever from an unknown source. Of these 21, 9 cases were from unknown causes and 4 cases were attributed to a viral syndrome resolved spontaneously or with empiric antibiotics. The remaining 8 sought medical care and were evaluated as described below.
Medical care was sought by 8% (59) of all travelers, or 12% of those who reported illness ( Table 5 ). Those who sought medical care were younger (mean age 37.1 Ϯ 20.7 years) than those who did not seek medical care (43.9 Ϯ 17.2 years, p = .005), and had a longer duration of their trip (mean duration, 32.1 Ϯ 19.8 days vs. 25.2 Ϯ 16.1, p = .003). Also, children ≤ 12 years (n = 9) made up a disproportionate number of cases (16% of those seeking care vs. 4% of those not seeking care, p < .001). The site of care was from a local physician, clinic or hospital in 76% of cases, a ship or hotel physician in 14%, and a relative or member of the trip in 8%.
The most common reason for obtaining care was for gastrointestinal illness, followed by respiratory tract symptoms. Of the 8 persons seeking care for undiagnosed febrile syndromes, 2 had documented Plasmodium falciparum malaria, 4 were treated presumptively for malaria, and 1 each for otitis media and pharyngitis. Evaluation for malaria occurred in Ghana (3), India (1), Kenya (1), and Nigeria (1) . Five of the 6 persons evaluated for malaria were on appropriate chemoprophylaxis; 1 with documented P. falciparum, purchased, but never took the prescribed chemoprophylaxis. Ten of those who sought medical care (17%) had injections, the most frequent reason was for the treatment of malaria. Two patients were hospitalized, 1 for malaria and 1 for angina.
Illness Following Travel
Two months following the trip, 779 (99%) of the 784 travelers were contacted. Illness on or after return home was reported by 202 (26%) ( Table 6 ). There were 235 illnesses,or 1.2 Ϯ 0.4 illnesses per traveler.Diarrhea occurred most commonly. For 70% of these patients, illness began after return, starting after a mean of 3.3 Ϯ 3.7 days, and lasting 6.3 Ϯ 6.1 days, which was longer than the duration of diarrhea during travel (p < .001). Eighty-one percent met the definition for traveler's diarrhea. Upper respiratory symptoms, skin problems (rash, urticaria and ectoparasites), and febrile episodes requiring separate medical evaluation, followed in frequency.
Ninety-three travelers sought medical care for their illness following travel (Table 7) . This number was 12% of all travelers, but 46% of those who were ill. The most common reasons were for gastrointestinal problems (31%), respiratory tract illness (24%), febrile episodes (13%), or skin problems (11%). The 2 cases of hepatitis had mild elevation of liver enzymes which tested negative for type A or B hepatitis. Four patients were hospitalized, 1 each for surgical repair of an ankle fracture, P. falciparum malaria, dengue fever, and cellulitis. 
Compliance and Side Effects with Antimalarial Chemoprophylaxis
Six hundred and twelve travelers were prescribed malaria chemoprophylaxis: 63% chloroquine alone, 18% chloroquine plus proguanil, 17% mefloquine, and 2% other medications. Compliance information was available from 99% (608) ( Table 8 ). Eighty percent stated that they were completely compliant, indicating that they had filled the prescription, and taken the prescribed number of doses before, during, and following their trip. The mean number of chloroquine or mefloquine pills not taken in the noncompliant group was 4.0 Ϯ 2.8 pills. Only 2.1% never filled their chloroquine or mefloquine prescription and took no chemoprophylaxis. For those who were noncompliant with proguanil, 90% (28/31) never obtained the medication. Noncompliant travelers were younger (37.4 Ϯ 17.2 years vs. 45.2 Ϯ 17.6 years, p < .001), and traveled longer (28.9 Ϯ 20.8 days vs. 22.5 Ϯ 14.4 days, p < .001) than those who were compliant. No traveler took a treatment dose of fansidar for suspected malaria.
Thirty-nine individuals experienced side effects secondary to antimalarial medications; 72% of these occurred during the trip and 28% following return.
Gastrointestinal side effects were the most common for those on chloroquine alone, and 3 persons discontinued the medication because of them. Of those on combination chloroquine and proguanil, gastrointestinal problems were most frequent, however, two persons developed urticaria. Problems with mefloquine were equally divided between gastrointestinal complaints (7) , and central nervous system problems (7) (headache, dizziness, coordination difficulty, nightmares, or emotional lability). No person discontinued mefloquine. Side effects with mefloquine, or with chloroquine plus proguanil, occurred significantly more often than with chloroquine alone (see Table 8 ).
Discussion
This 2-year prospective study followed the health of a large cohort of Americans who traveled to countries in the developing world. There were nearly 800 travelers studied who ranged in age from 1 year to 85 years and visited 123 countries. Other studies have examined small numbers of travelers to single destinations, and focused, for example, on traveler's diarrhea, 6, 8, 14 or have studied a limited number of travelers to more diverse destinations. [2] [3] [4] But a study which examines a wide range of illness both during and after travel with a near complete follow-up has not been done on Americans. Although travelers were asked to recall illness, they knew prior to travel that they would be asked to report on their health, and were contacted shortly after return, hopefully minimizing recall bias.
In this series, 64% of travelers experienced some health complaint during travel. Although this number is higher than the 15% found in Swiss travelers 15 and in one group of American travelers (22% incidence 1 ), it is not dissimilar from the 43% illness found in Scottish package tourists, 16 49% illness in Swedes, 17 and 39% incidence in another group of Americans. 3 The higher frequency of illness in this study is likely because travelers were encouraged to report any problem in a wide range of conditions, and the trip duration extended to 90 days.
Travelers who were ill tended to be younger, were more often female, and had a longer duration of travel than those who remained well. For all destinations, duration of travel correlated most strongly with risk of illness, with each additional day of travel adding a 3 to 4% increased risk, such that 80% of travelers away for more than 30 days, became ill. This increased cumulative risk of illness over time, has been seen in studies of expatriates, 18, 19 and emphasizes the need for thorough counseling of longer term travelers. For most, illness was mild and did not require a change in their plans. For many others, however, illness interfered with travel, and one out of every 13 travelers had to obtain medical care. Diarrhea and respiratory tract symptoms, experienced by 46% and 26% of travelers respectively, were the most common complaints both during, and immediately after travel. They were also the most common reasons for which people sought medical care. In all surveys of health overseas, these two illnesses account for the highest percentage of health problems. [1] [2] [3] [4] [15] [16] [17] This percent of travelers with diarrhea is similar to that of other studies in which the range is 20 to over 50%. [5] [6] [7] 13, [20] [21] [22] It was hoped that with uniform pretravel counseling the incidence of diarrhea would be less. However, this group fared no better than others reported in the literature, and indicates that even with careful pretravel counseling it is difficult to completely avoid contaminated foods and liquids. 4, [22] [23] [24] [25] [26] The 26% incidence of respiratory illness was within the reported range of 7 to 29%. 1, 3, 4, 16, 17 For the 1 out of every 4 travelers who experienced cough, sore throat, runny nose, or ear ache, illness lasted a long time, an average of 11 days. Since the median trip duration was 19 days, they were affected with these symptoms for over half of their trip. Given this high incidence, it is appropriate to counsel travelers to carry symptomatic treatment for respiratory infections. Similarly, with the 8% incidence of skin problems, travelers should protect their skin against the effects of sun and heat, and be able to treat superficial fungal infections.
Other adverse health events occurred with less frequency, although their implications remain important. Nearly 5% experienced accidents and injuries. Although for most of these travelers the problems were minor, consisting of cuts, abrasions or bruises, for one-third, the injuries were potentially severe vehicular accidents, major orthopedic trauma, assault and near drowning. When morbidity and mortality are examined in overseas travelers, accidents and injuries account for 20 to 25% of deaths when all ages are considered. 27, 28 and up to 70% when young adults, such as Peace Corps workers, have been studied. 29 Education about personal safety is a critical part of pretravel education.
Most febrile episodes were associated with diarrhea or respiratory illness.However,3% of travelers experienced fever from a source which was not readily identified. The majority of these episodes resolved spontaneously or with empiric antibiotic treatment. For those who required medical evaluation, the most common reason for the fever was attributed to malaria. Three persons had smeardocumented P. falciparum malaria (including 1 returned traveler), and 4 others were treated presumptively for malaria. Malaria is commonly felt to be the cause of febrile episodes overseas, even though most of these febrile episodes are not documented to be malaria. 30, 31 The incidence of documented malaria was 3.8 cases/1,000 travelers, and the incidence of documented plus presumptive malaria was 8.9 cases/1,000 travelers. This incidence of documented disease is similar to other large surveys, which report a range of 0.7 to 18 cases per 1,000 travelers. 10, 30, [32] [33] [34] [35] Incidence depends upon travel destination and use of chemoprophylaxis; travel to West Africa is always associated with the highest risk of malaria. All 3 of the documented cases in this series were acquired in West Africa. In these cases, 1 person took no chemoprophylaxis, and 2 were on combination chloroquine/proguanil before the availability of mefloquine.
One of the most important findings was the frequency with which medical care was ought overseas. One out of every 13 travelers obtained medical care, and 1 out of 8 who experienced an illness. Care was particularly obtained for young children. Information about accessing appropriate medical care is infrequently provided to the traveler by travel medicine clinics, 36 and yet, aside from diarrhea and respiratory illness, was the most frequent health need of travelers to developing countries. 4, 37, 38 While the quality of this care is difficult to assess, it is notable that 17% of those who sought care received injections, a potential risk for blood borne pathogens. Since diarrhea and other illness can usually be treated orally, most injections were probably unnecessary. All travelers should be provided information about accessing health care overseas. Information can be obtained through commercial travel health insurance companies, embassies or other private organizations. 39 The range of illness on return was very similar to that experienced overseas-diarrheal illness, respiratory infections, skin rashes, and febrile episodes. In 44% of cases, illnesses were a continuation of that which began overseas. However, nearly 60% of illness developed after return, emphasizing the importance of following travelers after return to obtain a complete understanding of illness associated with travel. Of ill returned travelers, 46% sought medical care for their symptoms, compared with 12% of those who were ill during their trip. Unusual diseases such as dengue fever, malaria and Mediterranean Spotted Fever were seen. All health care professionals should elicit a travel history and have familiarity with the diagnostic approach to travel related illness when seeing ill returned travelers. [40] [41] [42] Vaccine preventable diseases such as typhoid and hepatitis A were not seen probably because of their relatively low incidence, 15, 43, 44 and because of protection of travelers at risk.
Compliance with antimalarials at 80% was much higher than the approximately 50% compliance reported in other large surveys of European and North American travelers. 30, 34, 45 The improved compliance in this study is probably secondary to careful, uniform and relatively simple recommendations, with the provision of written material, a theory supported by other studies. 9, 45 If regimens are complex, 45 or inaccurate, 46 compliance will be less. The lowest compliance was seen in those who were prescribed chloroquine and proguanil, which required obtaining proguanil overseas; 26% of travelers failed to do so. For travelers who were noncompliant, medication was usually discontinued upon return.
Antimalarial side effects were few, and only rarely required that the traveler discontinue the medication. Chloroquine as a single agent was the best tolerated when compared with combining it with proguanil, or with mefloquine taken alone. 34, 35 Neuropsychiatric problems with mefloquine occurred in 7%, about the range seen in recent surveys of mefloquine use. 35, 47, 48 This study defines the range of illness in a diverse group of American travelers. By understanding the health experience of travelers, the travel health provider can better counsel patients and emphasize the prevention and care of diarrheal and respiratory illness, compliance with antimalarial medications, the provision for personal safety, and the mechanism to access medical care overseas. For the returned traveler it is important to take a proper history to be aware of the full range of imported illness. Attention to both the pre-and post-travel care will contribute to healthy travel overseas.
